Virus cocktail takes on superbug UTIs in tiny new trial
NCT ID NCT07382271
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests whether a personalized mix of viruses (called phages) can safely treat urinary tract infections caused by drug-resistant bacteria. Six adults aged 18–65 will receive the phage cocktail through a catheter every 12 hours for 2–3 days. Researchers will monitor side effects, how well the bacteria are cleared, and whether symptoms improve over 2–4 weeks of follow-up.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- personalized phage cocktail (viruses that kill specific bacteria)
- What this could lead to
- If it works, this could point toward a new treatment option for people with stubborn urinary tract infections that don't respond to antibiotics.
- What could go wrong
- This is a very early, tiny study with only 6 people, so results may not apply broadly. Phage therapy can cause allergic reactions or fail to clear the infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY TRACT INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can better school toilets and peer support boost girls' health and grades? a madagascar trial aims to find out.
- Antibiotic levels in breast milk under the microscope
- Can antibiotic wash and suction stop Post-Surgery infections?
- Gut bacteria transplant shows promise for recurring UTIs
- Simple bathroom habit may cut infection risk after kidney transplant
- Antibiotics before kidney drainage: help or hype?